AVTAR S DHILLON Insider Trading $GEB INOVIO PHARMACEUTICALS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for AVTAR S DHILLON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of AVTAR S DHILLON. AVTAR S DHILLON is Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and President & CEO in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in Vitality Biopharma, Inc. ($STVF) and Director in ONCOSEC MEDICAL Inc ($ONCS.D) and Director in Nemus Bioscience, Inc. ($NMUS) and Director in Arch Therapeutics, Inc. ($ARTH).

Over the past year AVTAR S DHILLON has been an insider in 1 company. The total value of shares held by AVTAR S DHILLON in this company amounts to $71,360.

AVTAR S DHILLON Director
Arch Therapeutics, Inc.
Director, President & CEO
INOVIO PHARMACEUTICALS, INC.
Director
ONCOSEC MEDICAL Inc
Director
Skye Bioscience, Inc.
Director
Vitality Biopharma, Inc.
$ 71360 The total value of shares held by AVTAR S DHILLON
Insider Rank

AVTAR S DHILLON ranks 30,957 out of 350,000 insiders. Go to Insider Ranking to see more.

AVTAR S DHILLON in INOVIO PHARMACEUTICALS, INC.

Trading Symbol: GEB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of AVTAR S DHILLON: Director, President & CEO
Holdings: 106,002 shares
Latest Transaction: Dec 06 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 47,669
Shares Sold: 0
Share Difference: +47,669
Value Difference: -$50,000

Latest Insider Trading Transactions of AVTAR S DHILLON in INOVIO PHARMACEUTICALS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARTH, GEB, ONCS, NMUS, VBIO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 06 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM2.0025,00050,0000
Dec 06 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM2.0025,00050,000106,00281 K to 106 K (+30.86 %)
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.007,66900
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.008,17008,170
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA4.5612,50057,00012,500
May 14 2018GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.007,669081,00273.3 K to 81 K (+10.46 %)
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.0010,00000
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA7.1412,50089,25012,500
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.007,66907,669
May 15 2017GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.0010,000073,33363.3 K to 73.3 K (+15.79 %)
May 16 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA9.3310,00093,30010,000
May 16 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.0010,000010,000
May 09 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseM0.005,00000
May 09 2016GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorBuyM0.005,000063,33358.3 K to 63.3 K (+8.57 %)
May 08 2015GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA8.017,50060,0757,500
May 08 2015GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SDirectorOption ExerciseA0.005,00005,000
Jan 19 2005GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOOption ExerciseA3.82150,000573,000150,000
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.566,60016,89660,18753.6 K to 60.2 K (+12.32 %)
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.554001,02053,58753.2 K to 53.6 K (+0.75 %)
Oct 14 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP2.443,0007,32053,18750.2 K to 53.2 K (+5.98 %)
Sep 15 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOOption ExerciseP8.801,0299,0551,029
Sep 15 2004GEBINOVIO PHARMACEUTI ...DHILLON AVTAR SPresident & CEOBuyP11,764.70223,52920 to 2

Page:   1